Portfolio News

Corbus Pharmaceuticals to Present at the 7th Annual LEERINK Partners Global Healthcare Conference

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical-stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present in a fireside chat at the 7th Annual LEERINK Partners Global Healthcare Conference on Thursday, February 15th at 2:30 p.m. EST in New York, NY. Read more >>
Read more...

Two Boston finalists named for 2018 SXSW Accelerator Pitch Event

From computers that can read human body language to teaching moms how to do computer coding, a wide variety of ideas are being peddled by the dozens of companies invited to pitch their business plans to a panel of expert judges at this year's South by Southwest Accelerator Pitch Event...Two companies from Boston are in the mix: FutureFuel.io, a student debt-focused startup; and Nix, the maker of a hydration biosensor that informs athletes, soldiers, and laborers when to drink, what...
Read more...